A PLAIN-LANGUAGE SUMMARY OF THE SOLAR-1 TRIAL: STUDYING ALPELISIB WITH FULVESTRANT IN PATIENTS WITH HR+, HER2-ADVANCED BREAST CANCER WHO HAD PREVIOUSLY RECEIVED AN AROMATASE INHIBITOR

著录项

• 来源
  《The Breast :》 |2019年第2期|共1页
• 作者

  Aubel Dawn; Loibl Sibylle; Kaufman Bella; Lu Yen-Shen; Juric Dejan; Mayer Ingrid; Ciruelos Eva; Campone Mario; Conte Pierfranco; Iwata Hiroji; Rugo Hope; Ghaznawi Farhat; Gillis Kathryn; Mills David; Andre Fabrice;

  展开▼
• 作者单位

  Novartis Pharmaceut Global Patient Relat E Hanover NJ USA;

  German Breast Grp Dept Med &

  Res Neu Isenburg Germany;

  Chaim Sheba Med Ctr Radiat Oncol Tel Aviv Israel;

  Natl Taiwan Univ Hosp Oncol Taipei Taiwan;

  Massachusetts Gen Hosp Oncol Hematol Boston MA 02114 USA;

  Vanderbilt Ingram Canc Ctr Hematol Oncol Nashville TN USA;

  Hosp Univ 12 Octubre Med Oncol Madrid Spain;

  Inst Cancerol Ouest Oncol Nantesz France;

  Ist Oncol Veneto IRCCS Med Oncol Padua Italy;

  Aichi Canc Ctr Hosp Breast Oncol Nagoya Aichi Japan;

  UCSF Helen Diller Family Comprehens Canc Ctr Med Hematol Oncol San Francisco CA USA;

  Novartis Pharmaceut Clin Dev E Hanover NJ USA;

  Novartis Pharmaceut Global Med Affairs E Hanover NJ USA;

  Novartis Pharma AG Oncol Global Dev Unit Basel Switzerland;

  Inst Gustave Roussy Med Oncol Villejuif France;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 胸部外科学;
• 关键词